CervoMed is trading 5.17% down now at $2.57 after broader U.S. equities weakened on August 20, 2026.
- The S&P 500, Nasdaq Composite, and Dow Jones were all lower as rising Treasury yields, geopolitical tensions, and fading risk appetite pressured stocks.
- Searches found no verified company-specific announcement dated August 20.
- The latest material updates were its August 10 quarterly results and August 11 conference presentation.